Sign inJoin waitlistJoin the waitlist

Scott Ramsey

Director, Hutchinson Institute for Cancer Outcomes Research (HICOR) Fred Hutchinson Cancer Research Center · University of Washington School of Medicine

Credentials: · · ·

History

Hutchinson Institute for Cancer Outcomes Research (HICOR) Fred Hutchinson Cancer Research Center · University of Washington School of Medicine
Present
University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Seattle VA Medical Center 1995–
1995–1996
Internal Medicine
University of Washington-Seattle Campus
1990–1993
Health Economics, University of Pennsylvania
University of Iowa Roy J. and Lucille A. Carver College of Medicine
1986–1990

Research

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability
Journal of the National Cancer Institute · 2004 · 2,401 citations
Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest…
Journal of Clinical Oncology · 2001 · 911 citations
The case for early detection
Review · Nature reviews. Cancer · 2003 · 797 citations

Dawn Hershman
45 papers
Veena Shankaran
31 papers
David Penson
21 papers
BG
Bernardo Goulart
17 papers
Gary Lyman
17 papers
IT
Ian Thompson
14 papers · 7 as a resident
MA
Molly Arnold
13 papers
JG
Julie Gralow
9 papers
MB
Michael Bender
9 papers
Hannah Linden
8 papers
JM
Jeanne Mandelblatt
8 papers
LB
Laurence Baker
8 papers

Grants

Financial and Clinical Outcomes Among Commercially-Insured Cancer Patients Following the Affordable Care Act
National Cancer Institute · R01
Contact PI · $1.2M · Fred Hutchinson Cancer Center
2024–2028
NCI Cancer Screening Research Network: Coordinating and Communication Center
National Cancer Institute · UG1
PI · $12.6M · Fred Hutchinson Cancer Center
2024–2027
The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site
National Cancer Institute · UG1
PI · $2.7M · Swedish Medical Center, First Hill
2025–2026
The Cure Sickle Cell Initiative Economic Analysis: An Evaluation of the Costs of Sickle Cell Disease and Potential Health Plan Budget Impacts of Gene Therapy as a New Treatment Option
National Heart, Lung, and Blood Institute · OT3
Contact PI · $727.5K · Fred Hutchinson Cancer Center
2019–2023

Clinical trials

The Vanguard Study: Testing a New Way to Screen for Cancer
Principal investigator · Recruiting
National Cancer Institute (NCI)
2025–2029
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Principal investigator · Completed
SWOG Cancer Research Network
2016–2021
S1204, Viral Screening in Newly Diagnosed Cancer Patients
Study chair · Completed
SWOG Cancer Research Network
2013–2022